TRIP13 and nonpapillary renal cell carcinoma: In ccRCC, high expression of TRIP13 is an independent poor prognostic indicator for ccRCC survival, which may be an important driving factor for systemic treatment resistance in renal cancer, but its specific mechanism is still unclear (Chen X. et al., 2025).